1H-咪唑-4,5-二羧酸二乙酯, 98%

Diethyl 1H-imidazole-4,5-dicarboxylate

3-甲氧基苯甲硫醚

3-Methoxy thioanisole

>98.0%(GC)

3,3-二甲基-四氢吡喃-4-酮, 98%

3,3-Dimethyldihydro-2H-pyran-4(3H)-one

(S)-2-氨基-2-(3-氯苯基)乙醇盐酸盐, 98%

(S)-2-Amino-2-(3-chlorophenyl)ethanol hydrochloride

[1,3-双（2,6-二-异丙基苯基）咪唑烷基-2-亚甲基）（三环己基膦）-（2-氧代亚苄基）氯化钌（II）LatMet SIPr

[1,3-Bis(2,6-di-i-propylphenyl)imidazolidin-2-ylidene)(tricyclohexylphosphine)-(2-oxobenzylidene)ruthenium(II) chloride LatMet SIPr

98%

5-(氯甲基)-2,2-二氟苯并[d][1,3]二氧杂环戊烯, 98%

5-(Chloromethyl)-2,2-difluorobenzo[d][1,3]dioxole

奈韦拉平相关化合物B

Pharmaceutical Secondary Standard; Certified Reference Material

1-[2-(甲硫基)苯基]-2-硫脲

1-[2-(Methylthio)Phenyl]-2-Thiourea

98%

4-氯-6,7-二甲氧基喹啉, 99%

4-Chloro-6,7-dimethoxyquinoline

2-(2-氮杂双环[2.2.1]-2-庚基)乙酸乙酯, 98%

Ethyl 2-(2-azabicyclo[2.2.1]heptan-2-yl)acetate

5-甲氧基-1H-苯并咪唑-2-胺, 98%

5-Methoxy-1H-benzimidazole-2-ylamine

(4S,4'S)-2,2'-环己亚基双[4-叔丁基-4,5-二氢噁唑], 98%

(4S,4'S)-2,2'-(Cyclohexane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole)

1-(2-氰基苯基)哌啶-4-甲酸, ≥98%

1-(2-Cyanophenyl)piperidine-4-carboxylic Acid

(S)-(-)-2-(二苯甲基)吡咯烷, 99%

(S)-(-)-2-(Diphenylmethyl)pyrrolidine

2'-氟-4'-甲基联苯-3-羧酸

2'-Fluoro-4'-methylbiphenyl-3-carboxylic acid

98%

Azido-dPEG ^®₄-TFP ester

Azido-dPEG ®₄-TFP ester

十五氟辛酸甲酯, ≥98%

Methyl Pentadecafluorooctanoate

(4-甲氧基苯基)(4-哌啶基)甲酮盐酸盐, 98%

4-(4-Methoxybenzoyl)piperidine hydrochloride

（二甲基苯基膦）（1,5-环辛二烯）[1,3-双（2,4,6-三甲基苯基）咪唑-2-亚基]六氟磷酸铱（I）

(Dimethylphenylphosphine)(1,5-cyclooctadiene)[1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene]iridium(I) hexafluorophosphate

≥99%

N，N′′-[双（2，6-二甲基苯基）-1，3-二甲基-1，3-丙二叉基]（甲基）（三乙基膦）钯（II）

N,N''-[Bis(2,6-dimethylphenyl)-1,3-dimethyl-1,3-propanediylidene](methyl) (triethylphosphine)palladium(II)

≥99%